SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Rhinovirus: A Narrative Review on Its Genetic Characteristics, Pediatric Clinical Presentations, and Pathogenesis.

Bizot, E; Bousquet, A; Charpié, M; Coquelin, F; Lefevre, S; Le Lorier, J; Patin, M; Sée, P; Sarfati, E; Walle, S; et al. Bizot, E; Bousquet, A; Charpié, M; Coquelin, F; Lefevre, S; Le Lorier, J; Patin, M; Sée, P; Sarfati, E; Walle, S; Visseaux, B; Basmaci, R (2021) Rhinovirus: A Narrative Review on Its Genetic Characteristics, Pediatric Clinical Presentations, and Pathogenesis. Front Pediatr, 9. p. 643219. ISSN 2296-2360 https://doi.org/10.3389/fped.2021.643219
SGUL Authors: Basmaci, Romain

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Human rhinoviruses (HRVs) are the leading cause of common colds. With the development of new molecular methods since the 2000s, HRVs have been increasingly involved among severe clinical infections. Recent knowledge of the HRV genetic characteristics has also improved the understanding of their pathogenesis. This narrative review aims to provide a current comprehensive knowledge about this virus in the pediatric community. HRVs represent a main cause of upper and lower respiratory tract infections in children. HRV is the second virus involved in bronchiolitis and pneumonia in children, and HRV bronchiolitis has a higher risk of recurrent wheezing episode or asthma. Some recent findings described HRVs in stools, blood, or cerebrospinal fluid, thanks to new molecular techniques such as polymerase chain reaction (PCR) by detecting HRVs with high sensibility. However, the high rate of asymptomatic carriage and the prolonged excretion in postsymptomatic patients complicate interpretation. No sufficient data exist to avoid antibiotic therapy in pediatric high-risk population with HRV detection. Severe clinical presentations due to HRVs can be more frequent in specific population with chronic pathology or genetic particularity. Inflammatory response is mediated by the nuclear factor (NF)-kappa B pathway and production of interferon (IFN)-beta and IFN-gamma, interleukin 8 (IL8), and IL1b. No specific treatment or antiviral therapy exists, although research is still ongoing. Nowadays, in addition to benign diseases, HRVs are recognized to be involved in some severe clinical presentations. Recent advances in genetic knowledge or specific inflammatory response may lead to specific treatment.

Item Type: Article
Additional Information: Copyright © 2021 Bizot, Bousquet, Charpié, Coquelin, Lefevre, Le Lorier, Patin, Sée, Sarfati, Walle, Visseaux and Basmaci. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Keywords: children, enterovirus, respiratory tract infection, respiratory virus, rhinovirus, rhinovirus, respiratory virus, children, enterovirus, respiratory tract infection, 1114 Paediatrics and Reproductive Medicine, 1199 Other Medical and Health Sciences
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Front Pediatr
ISSN: 2296-2360
Language: eng
Dates:
DateEvent
22 March 2021Published
3 February 2021Accepted
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 33829004
Web of Science ID: WOS:000636575600001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114684
Publisher's version: https://doi.org/10.3389/fped.2021.643219

Actions (login required)

Edit Item Edit Item